Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.
Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. Braicu C, et al. Among authors: gulei d. Cancers (Basel). 2019 Oct 22;11(10):1618. doi: 10.3390/cancers11101618. Cancers (Basel). 2019. PMID: 31652660 Free PMC article. Review.
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.
Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RS. Fuentes-Mattei E, et al. Among authors: gulei d. JCI Insight. 2020 Jan 16;5(1):e121781. doi: 10.1172/jci.insight.121781. JCI Insight. 2020. PMID: 31941838 Free PMC article.
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Sas V, Pasca S, Jurj A, Pop L, Muramatsu H, Ono H, Dima D, Teodorescu P, Iluta S, Turcas C, Onaciu A, Munteanu R, Zimta AA, Blag C, Popa G, von Gamm EDA, Arghirescu S, Serban M, Man S, Marian M, Petrushev B, Berce C, Colita A, Zdrenghea M, Kojima S, Gulei D, Takahashi Y, Tomuleasa C. Sas V, et al. Among authors: gulei d. Cell Physiol Biochem. 2020 Oct 3;54(5):994-1012. doi: 10.33594/000000283. Cell Physiol Biochem. 2020. PMID: 33006449 Free article.
The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A.
Zimta AA, Hotea I, Brinza M, Blag C, Iluta S, Constantinescu C, Bashimov A, Marchis-Hund EA, Coudsy A, Muller-Mohnssen L, Dirzu N, Gulei D, Dima D, Serban M, Coriu D, Tomuleasa C. Zimta AA, et al. Among authors: gulei d. Front Med (Lausanne). 2021 Apr 15;8:654197. doi: 10.3389/fmed.2021.654197. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33968959 Free PMC article. Review.
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
Iluta S, Pasca S, Gafencu G, Jurj A, Terec A, Teodorescu P, Selicean C, Jitaru C, Preda A, Cenariu D, Constantinescu C, Iordache M, Tigu B, Munteanu R, Feder R, Dima D, Zdrenghea M, Gulei D, Ciuleanu TE, Tomuleasa C. Iluta S, et al. Among authors: gulei d. J Cell Mol Med. 2021 Jul;25(13):6094-6102. doi: 10.1111/jcmm.16513. Epub 2021 Jun 16. J Cell Mol Med. 2021. PMID: 34132464 Free PMC article.
71 results